These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36651792)

  • 1. Olopatadine/mometasone (Ryaltris) for allergic rhinitis.
    Med Lett Drugs Ther; 2023 Jan; 65(1668):12-14. PubMed ID: 36651792
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison table: Some nasal sprays for allergic rhinitis.
    Med Lett Drugs Ther; 2021 Apr; 63(1622):e66-e71. PubMed ID: 33848283
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for allergic rhinitis and allergic conjunctivitis.
    Med Lett Drugs Ther; 2021 Apr; 63(1622):57-64. PubMed ID: 33848281
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.
    Ridolo E; Barone A; Nicoletta F; Paoletti G; Heffler E; Malvezzi L; Canonica GW
    Expert Rev Clin Immunol; 2023 Jun; 19(6):575-584. PubMed ID: 37038974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic Rhinitis: A Review.
    Bernstein JA; Bernstein JS; Makol R; Ward S
    JAMA; 2024 Mar; 331(10):866-877. PubMed ID: 38470381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.
    Samoliński B; Wojas O; Lipiec A; Krzych-Fałta E; Walkiewicz A; Borowicz J; Samoliński K
    Otolaryngol Pol; 2023 Dec; 77(6):43-50. PubMed ID: 38706259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Brief: OTC azelastine nasal spray 0.15% (Astepro Allergy) for allergic rhinitis.
    Med Lett Drugs Ther; 2022 Oct; 64(1662):175-176. PubMed ID: 36383771
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
    Wolthers OD
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.
    Hampel FC; Pedinoff AJ; Jacobs RL; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Jul; 40(4):261-272. PubMed ID: 31053180
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
    Klimek L; Bousquet J; Price D
    Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis.
    Lim L; Lipari M; Kale-Pradhan P
    Ann Pharmacother; 2023 May; 57(5):570-578. PubMed ID: 36123818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of twice-daily olopatadine-mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis.
    Chen R; Zheng D; Zhang Y; Sima G
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1691-1699. PubMed ID: 34591150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azelastine and fluticasone nasal spray: any advantage?
    Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis.
    Kaliner MA; Storms W; Tilles S; Spector S; Tan R; LaForce C; Lanier BQ; Chipps B
    Allergy Asthma Proc; 2009; 30(3):255-62. PubMed ID: 19549426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of the combination of azelastine hydrochloride and mometasone furoate for the intranasal application in the patients presenting with seasonal allergic rhinitis].
    Karpishchenko SA; Kolesnikova OM
    Vestn Otorinolaringol; 2017; 82(5):44-47. PubMed ID: 29072663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.
    Gross GN; Berman G; Amar NJ; Caracta CF; Tantry SK
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):630-638.e3. PubMed ID: 30910440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.